Empagliflozin + Linagliptin
Antidiabetic
PRESENTATION:
Empala L Tablet: Each Flim coated tablet contains Empagliflozin INN 10 mg & Linagliptin INN 5 mg.
INDICATION:
Empala L is indicated:
• As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
• To reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease Limitations of use:
• Not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
• Has not been studied in patients with a history of pancreatitis
• Not recommended for use to improve glycemic control in adults with Type 2 diabetes mellitus with an eGFR less than 30 mL/min/1.73 m
PACKAGING:
Empala L 10/5 Tablet: Each box contains 20 tablets in Blister pack